Results 171 to 180 of about 74,631 (338)

Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Real‐world evidence on treatment practices in Parkinson's disease (PD) has been limited due to the difficulty in collecting comprehensive and generalizable clinical data. Objectives We sought to identify treatment patterns and test how treatment changed in response to (1) falling, (2) worsening disease, and (3) worsening quality of ...
Nabila Dahodwala   +11 more
wiley   +1 more source

The Changing Face of Dystonia—Enhancing Diagnosis by Moving Beyond Traditional Clinical Phenotyping

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Niroshan Jeyakumar, Kishore R. Kumar
wiley   +1 more source

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS‐Park Cohort

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Impulse control disorders (ICD) are common non‐motor complications in Parkinson's disease (PD), particularly in patients receiving oral dopamine agonists (DA). Continuous subcutaneous apomorphine infusion (CSAI) is a device‐aided therapy for advanced PD, but its effects on ICD remain underexplored in real‐world settings.
Clément Desjardins   +249 more
wiley   +1 more source

Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. [PDF]

open access: green, 1990
SG Bowes   +8 more
openalex   +1 more source

The Mild Behavioral Impairment Checklist for Parkinson's Disease: An Ancillary Instrument in Cognitive Assessment

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Mild behavioral impairment (MBI) is a syndrome characterized by the later‐life onset of neuropsychiatric symptoms (NPS) and serves as a potential marker for dementia. In Parkinson's disease (PD), MBI has been associated with worse cognition, cortical atrophy, and altered connectivity.
Gabriel D. Pinilla‐Monsalve   +4 more
wiley   +1 more source

The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers. [PDF]

open access: green, 1991
DR Robertson   +5 more
openalex   +1 more source

Early Levodopa Therapy in Tyrosine Hydroxylase Deficiency

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Claudio M. de Gusmao   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy